Information

We entered into a special agreement with the National University Corporation, the University of Tokyo (hereinafter referred to as “the University of Tokyo”), in 2021. Since the conclusion of this agreement, we have been collaborating with research institutions and laboratories affiliated with the University of Tokyo to advance the development of next-generation cutting-edge technologies. We …

Read more “On Multifaceted Cooperation and Collaboration between the Institute of Medical Science, The University of Tokyo, and Vaccine Research and Analysis”

We began the release of the Android application “FLD HbA1c” at the end of September 2025, and since December 17, 2025, we have commenced the release of “FLD SpO2,” which enables estimate of pulse rate and oxygen saturation. As of December 23, 2025, the FLD app series is available in 21 countries worldwide. We are …

Read more “In approximately three months, the number of accesses (including requests) to the SFM App Store has surpassed 350,000.”

Our company, after many years of foundational research, presented the accuracy evaluation of our completely contactless and non-invasive bioinformatic analysis technology for HbA1c estimate at the National Conference of the Japanese Society of Laboratory Medicine on August 29, 2025. In addition, we announced the Android version of our contactless, non-invasive LDL cholesterol estimate app on …

Read more “Regarding the Completion of the Development of the HDL Cholesterol Estimate App for iOS”

Starting from the end of September 2025, we commenced the release of the Android app “FLD HbA1c,” and from December 17, 2025, we began the release of “FLD SpO2,” which allows the estimate of pulse and oxygen saturation. By December 23, 2025, the FLD app series became available in 21 countries worldwide. We are pleased …

Read more “In just over 70 days, the number of accesses to the SFM App Store, including access requests, has exceeded 300,000.”

We are pleased to announce that the Android app “FLD SpO2” was officially released on December 17, 2025. We are also delighted to inform you that the availability of “FLD SpO2” has expanded to include three additional countries. The newly included countries are as follows: With this expansion, the usage of the FLD app series …

Read more “The number of countries where the FLD series app is available has increased.”

Our company has announced the accuracy evaluation of a completely non-contact, non-invasive biometric information analysis technology for HbA1c estimate at the National Conference of the Japanese Society of Laboratory Medicine, following years of fundamental research, on August 29, 2025. Additionally, we have announced the completion of the development of a non-contact, non-invasive LDL cholesterol estimate …

Read more “Regarding the Completion of Development of the HDL Cholesterol Estimate App for Android”

We are pleased to announce the launch of the Android application ‘FLD HbA1c’, which began at the end of September 2025, and the launch of ‘FLD SpO2’, capable of estimating pulse rate and oxygen saturation, available in 19 countries starting December 17, 2025. We would like to inform you that within approximately two months, the …

Read more “In approximately two months, the number of accesses to the SFM App Store, including access requests, has exceeded 250,000.”

We are pleased to announce the launch of FLD SpO2. Due to numerous requests for a detailed installation guide for the application, we have provided the necessary information below. The application can be obtained from our exclusive app store, the “SFM App Store.” Access the SFM App Store here. SFM App Store To use the …

Read more “Instructions for Installing the FLD App (FLD SpO2/FLD HbA1c)”

Our company began releasing the FLD HbA1c from the SFM App Store at the end of September 2025. From the end of October 2025, we initiated international releases and are currently distributing in 18 countries, including Japan. We are pleased to announce the upcoming launch of the ‘FLD SpO2,’ which is capable of estimating oxygen …

Read more “Regarding the Release of the New Product “FLD SpO2””

I am pleased to report that I participated in the completion ceremony for the new main building held on December 9, 2025. The ceremony was attended by key figures from the University of Tokyo, including the University President and the Director of the Institute for Quantitative Biosciences (IQB), among others. The ribbon-cutting ceremony Our company …

Read more “Attend the Inauguration Ceremony of the New Main Building of the Institute for Quantitative Biosciences (IQB) at the University of Tokyo”